Polar Asset Management Partners’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,543,000
Closed -$22.3M 893
2026
Q1
$22.3M Buy
1,543,000
+1,300,000
+535% +$18.6M 0.45% 37
2025
Q4
$3.46M Buy
+243,000
New +$2.39M 0.04% 301

Other funds holding FOLD

Polar Asset Management Partners's FOLD Position: Q2 2026 in Review

Polar Asset Management Partners sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 1,543,000 shares — an estimated $22.3M sold.

Polar Asset Management Partners first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $22.3M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Polar Asset Management Partners reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Polar Asset Management Partners sold 1,543,000 Amicus Therapeutics shares in Q2 2026, an estimated $22.3M.
  • Polar Asset Management Partners first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
  • Polar Asset Management Partners's Amicus Therapeutics position peaked at $22.3M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Polar Asset Management Partners's 13F filing for Q2 2026, filed 14 Aug 2026.